Baxter Healthcare Corp. recalled Metronidazole Injection USP, 500 mg per 100 mL, due to the presence of particulate matter identified as a cloth fiber, according to the FDA. The agency announced the Class I recall on Jan. 21, 2016.
How to tell if you have it
- Brand: Baxter
- Product: Metronidazole Injection USP, 500 mg per 100 mL (5 mg/mL), 100mL Sterile Single Dose Container bag
- Rx only, Baxter USA
- Product Code: 2B3421
- NDC: 0338-1055-48
- Lot #: P339135
- Expiration: 08/31/2017
- Quantity: 334,560 bags
The hazard
The recall addresses the presence of particulate matter identified as a cloth fiber in the Metronidazole Injection USP. The FDA classified this hazard as Class I.
Context
GovInfoNow's records show Baxter Healthcare Corp. has 34 other recalls on record since Sept. 21, 2012. Other recent recalls of similar products include the Baxter Amia Dialysis Set Recall (Sept. 1, 2017), the Brevibloc Injection recall due to discoloration (April 12, 2016), and the Sodium Chloride Irrigation recall due to insect contamination (Feb. 5, 2016). Additional recent recalls of similar products include the Cefazolin injection recall for particulate matter risk (July 24, 2026), the 0.9% Sodium Chloride Injection recall for fiberglass particulates risk (Aug. 17, 2026), and the LEO Pharma Adbry Injection recall for wool fiber contamination risk (Feb. 10, 2026).